InvestorsHub Logo
Followers 484
Posts 60847
Boards Moderated 18
Alias Born 09/20/2001

Re: BIOChecker4 post# 456272

Wednesday, 04/10/2024 2:57:22 PM

Wednesday, April 10, 2024 2:57:22 PM

Post# of 462048
CNS issues are complex...

Blarcamesine should be an approved drug if it does anything listed below, even though it takes years longer than the initial trial ran:

1) slowed decline
2) created modest improvement
3) treated negative symptomology with no negative impact
4) when given very early slowed or stopped degeneration
5) decreased anxiety and discomfort in patients

... and probably more that I didn't come up with off the top of my head.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News